Well J and J didn’t get a break with recalls and this is their new division that was purchased last year, Synthes.  Occasionally there are fires in surgery but we don’t need a product that could contribute and thus the recall and this is a class one so all need to stop using the product immediately. 

Johnson & Johnson Agrees to By Synthes $21.3 Billion

If you go back in history a few years with Synthes they had their subsidiary company Norian where four executives were charged with unlawful clinical trials and this too was a cement issue to where it reacted with blood to cause clots.  I have no idea if this is the same product or not.  BD

At Norian Four Executives Charged in Connection With Unlawful Clinical Trials – 3 Patients Died on the Operating Table


The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.



Post a Comment

Google Analytics Alternative